Expression of interferon-γ and interleukin-4 production in CD4+ T cells in patients with chronic heart failure

Heart and Vessels

Volumn 22, Issue 3, 2007, Pages 178-183

  Fukunaga, Takashi ^a   Soejima, Hirofumi ^a   Irie, Atsushi ^a   Sugamura, Koichi ^a   Oe, Yoko ^a   Tanaka, Tomoko ^a   Kojima, Sunao ^a   Sakamoto, Tomohiro ^a   Yoshimura, Michihiro ^a   Nishimura, Yasuharu ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Chronic heart failure; Inflammatory cytokines; Interferon ; T cell

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS; T LYMPHOCYTE ACTIVATION;

AGED; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CHI-SQUARE DISTRIBUTION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; STATISTICS, NONPARAMETRIC;

EID: 34249852372     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-006-0955-8     Document Type: Article

References (28)

1. M Jessup S Brozena 2003 Heart failure N Engl J Med 348 2007-2018 12748317 10.1056/NEJMra021498
2. AD Luster 1998 Chemokines - chemotactic cytokines that mediate inflammation N Engl J Med 338 436-445 9459648 10.1056/ NEJM199802123380706 1:CAS:528:DyaK1cXht1Wrsrc%3D
3. C Murdoch A Finn 2000 Chemokine receptors and their role in inflammation and infectious diseases Blood 95 3032-3043 10807766 1:CAS:528:DC%2BD3cXjt1equrk%3D
4. K Setsuta Y Seino T Ogawa T Ohtsuka K Seimiya T Takano 2004 Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system Circ J 68 747-750 15277733 10.1253/circj.68.747 1:CAS:528:DC%2BD2cXmvF2ksbk%3D
5. T Sugamori Y Ishibashi T Shimada N Takahashi T Sakane S Ohata Y Kunizawa S Inoue K Nakamura Y Ohta H Shimizu H Katoh N Oyake Y Murakami M Hashimoto 2002 Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy: Close correlation of tumor necrosis factor-alpha with systemic and local production of nitric oxide Circ J 66 627-632 12135128 10.1253/circj.66.627 1:CAS:528:DC%2BD38XlsF2ms7g%3D
6. P Aukrust T Ueland F Muller AK Andreassen I Nordoy H Aas J Kjekshus S Simonsen SS Froland L Gullestad 1998 Elevated circulating levels of C-C chemokines in patients with congestive heart failure Circulation 97 1136-1143 9537339 1:STN:280:DyaK1c7ps1Krtw%3D%3D
7. JK Damas L Gullestad T Ueland NO Solum S Simonsen SS Froland P Aukrust 2000 CXC-chemokines, a new group of cytokines in congestive heart failure-possible role of platelets and monocytes Cardiovasc Res 45 428-436 10728363 10.1016/S0008-6363(99)00262-X 1:CAS:528:DC%2BD3cXotFKnsA%3D%3D
8. JK Damas HG Eiken E Oie V Bjerkeli A Yndestad T Ueland T Tonnessen OR Geiran H Aass S Simonsen G Christensen SS Froland H Attramadal L Gullestad P Aukrust 2000 Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure Cardiovasc Res 47 778-787 10974226 10.1016/S0008-6363(00)00142-5 1:CAS:528:DC%2BD3cXmt1WqtbY%3D
9. B Levine J Kalman L Mayer HM Fillit M Packer 1990 Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 236-241 2195340 1:STN:280:By%2BA3cbptFY%3D
10. P Aukrust T Ueland E Lien K Bendtzen F Muller AK Andreassen I Nordoy H Aass T Espevik S Simonsen SS Froland L Gullestad 1999 Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 83 376-382 10072227 10.1016/ S0002-9149(98)00872-8 1:STN:280:DyaK1M7ntVCnsQ%3D%3D
11. MK Erol S Erol M Koruk M Ertek E Bozkurt 2004 Effects of interferon-alpha therapy on cardiac function in patients with chronic hepatitis B infection Heart Vessels 19 263-266 15799171 10.1007/ s00380-004-0780-x
12. H Hirota M Izumi T Hamaguchi S Sugiyama E Murakami K Kunisada Y Fujio Y Oshima Y Nakaoka K Yamauchi-Takihara 2004 Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure Heart Vessels 19 237-241 15372299 10.1007/s00380-004-0770-z
13. S Satoh JI Oyama N Suematsu T Kadokami N Shimoyama M Okutsu T Inoue M Sugano N Makino 2006 Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure Int J Cardiol 111 405-412 16271779 10.1016/j.ijcard.2005.08.021
14. A Yndestad AM Holm F Muller S Simonsen SS Froland L Gullestad P Aukrust 2003 Enhanced expression of inflammatory cytokines and activation markers in T cells from patients with chronic heart failure Cardiovasc Res 60 141-146 14522416 10.1016/S0008-6363(03)00362-6 1:CAS:528:DC%2BD3sXns12ku7Y%3D
15. T Tsutamoto A Wada K Maeda N Mabuchi M Hayashi T Tsutsui M Ohnishi M Sawaki M Fujii T Matsumoto M Kinoshita 2000 Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure J Am Coll Cardiol 35 714-721 10716475 10.1016/ S0735-1097(99)00594-X 1:CAS:528:DC%2BD3cXitVCjsbk%3D
16. T Hayashi K Sohmiya A Ukimura S Endoh T Mori H Shimomura M Okabe F Terasaki Y Kitaura 2003 Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart Heart 89 1236-1242 12975429 10.1136/heart.89.10.1236 1:CAS:528:DC%2BD3sXosFaltrs%3D
17. WH Yin JW Chen HL Jen MC Chiang WP Huang AN Feng MS Young SJ Lin 2004 Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 931-938 15131554 10.1016/ j.ahj.2003.11.021 1:CAS:528:DC%2BD2cXjsl2gsLw%3D
18. C Gabay I Kushner 1999 Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 448-454 9971870 10.1056/ NEJM199902113400607 1:STN:280:DyaK1M7it1KhtA%3D%3D
19. DJ Pinsky B Cai X Yang C Rodriguez RR Sciacca PJ Cannon 1995 The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta J Clin Invest 95 677-685 7532189 1:CAS:528:DyaK2MXjsV2rsrY%3D
20. B Chatterjee UE Nydegger P Mohacsi 2000 Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT 1 antagonists Eur J Heart Fail 2 393-398 11113716 10.1016/S1388-9842(00)00110-0 1:CAS:528:DC%2BD3MXktFCgtA%3D%3D
21. L Dalla Libera B Ravara A Angelini K Rossini M Sandri G Thiene G Battista Ambrosio G Vescovo 2001 Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure Circulation 103 2195-2200 11331262 1:CAS:528:DC%2BD3MXjvFOntrw%3D
22. M Fujii A Wada T Tsutamoto M Ohnishi T Isono M Kinoshita 2002 Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure Hypertension 39 952-957 12019275 10.1161/01.HYP.0000015613.78314.9E 1:CAS:528:DC%2BD38Xkt1agtrs%3D
23. M Yoshimura H Yasue K Okumura H Ogawa M Jougasaki M Mukoyama K Nakao H Imura 1993 Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 464-469 8425293 1:STN:280:ByyC2crksF0%3D
24. H Yasue K Obata K Okumura M Kurose H Ogawa K Matsuyama M Jougasaki Y Saito K Nakao H Imura 1989 Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy J Clin Invest 83 46-51 2521343 1:STN:280:BiaD1MzksVA%3D
25. W Johnson T Omland C Hall C Lucas OL Myking C Collins M Pfeffer JL Rouleau LW Stevenson 2002 Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J Am Coll Cardiol 39 1623-1629 12020489 10.1016/ S0735-1097(02)01814-4 1:CAS:528:DC%2BD38XktlGqurw%3D
26. K Maeda T Tsutamoto A Wada N Mabuchi M Hayashi T Tsutsui M Ohnishi M Sawaki M Fujii T Matsumoto M Kinoshita 2000 High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 1587-1593 11079662 10.1016/S0735-1097(00)00912-8 1:CAS:528:DC%2BD3cXosFKgsLg%3D
27. S Bellosta D Via M Canavesi P Pfister R Fumagalli R Paoletti F Bernini 1998 HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages Arterioscler Thromb Vasc Biol 18 1671-1678 9812903 1:CAS:528:DyaK1cXnvFShsbo%3D
28. M Aikawa E Rabkin S Sugiyama SJ Voglic Y Fukumoto Y Furukawa M Shiomi FJ Schoen P Libby 2001 An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro Circulation 103 276-283 11208689 1:CAS:528:DC%2BD3MXhtFaitr4%3D